Straits Times Index
3,291.11 +7.17 (+0.22%) Nikkei
27,772.89 +305.66 (+1.11%) Hang Seng
24,689.32 +561.47 (+2.33%) FTSE 100
7,589.66 +26.11 (+0.35%) BTC-USD
41,914.76 +175.37 (+0.42%) CMC Crypto 200
995.20 +0.45 (+0.05%)
Tilray Brands, Inc. (TLRY)
After hours:
| Previous close | 6.29 |
| Open | 6.32 |
| Bid | 5.94 x 21500 |
| Ask | 5.97 x 4000 |
| Day's range | 5.94 - 6.40 |
| 52-week range | 5.94 - 67.00 |
| Volume | |
| Avg. volume | 24,072,821 |
| Market cap | 2.785B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
3 Charts That Sum Up Tilray's Q2 Earnings
Tilray Brands (NASDAQ: TLRY) reported its latest quarterly results last week. Using three charts, I'll look at just what drove those improved numbers and whether Tilray had a good quarter or not, and determine if it looks to be a better buy right now. In the company's second-quarter results, for the period ending Nov. 30, 2021, Tilray reported net revenue of $155.2 million.
- Yahoo Finance Video
Cannabis: Tilray CEO explains why the company isn't waiting for U.S. legalization 'lottery ticket'
Tilray CEO Irwin Simon joins Yahoo Finance Live’s Julie Hyman to discuss the cannabis industry, why the company is pivoting to food and beverage brands, weed legalization in the U.S., and the end of a partnership with Budweiser.
- Zacks
After a Downbeat 2021, Will Marijuana ETFs Rebound in 2022?
Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.
